Saturday 17 October 2026
Export BHST’s income statement to Excel — free account
BioHarvest Sciences Inc.
BHST Consumer Defensive Packaged Foods
BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
1.85
0.15
+8.82%
Follow BHST
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 4 | 4 |
+8 more TTM periods Free account |
| (142.50%) | (103.29%) | (83.17%) | (200.22%) | ||
| (30.60%) | (31.71%) | (30.65%) | (38.97%) | ||
ROIC |
(64.30%) | (66.19%) | (69.80%) | (136.54%) | |
Return on Tangible Assets |
(47.22%) | (41.91%) | (35.76%) | (92.20%) | |
Average Days of Receivables |
42.98 | 33.03 | 30.84 | 27.21 | |
Free Cash Flow per Share |
(0.47) | (0.42) | (0.52) | (0.54) | |
Free Cash Flow |
(10.75) | (9.44) | (9.58) | (9.46) | |
Capital Expenditures |
(2.24) | (2.26) | (2.35) | (2.09) | |
| Other line items | |||||
Cash ROIC |
(27.82%) | (20.66%) | (18.77%) | (38.22%) | |
Accounts Receivable Turnover |
10.67 | 12.99 | 14.60 | 14.66 | |
Accounts Payable Turnover |
4.72 | 4.44 | 4.56 | 3.37 | |
Inventory Turnover |
2.94 | 3.17 | 3.42 | 3.50 | |
Average Days of Payables |
68.85 | 68.76 | 68.33 | 95.31 | |
Days of Inventory on Hand |
144.84 | 127.44 | 118.59 | 121.27 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
16.31% | 15.53% | 15.39% | 16.54% | |
Selling, General and Administrative Expense of Revenue |
60.63% | 60.15% | 60.10% | 61.44% | |
Share Based Compensation of Revenue |
2.69% | 1.94% | 1.73% | 1.82% | |
Interest Coverage |
(1.31) | (0.98) | (1.01) | (1.49) | |
Operating CF/Net income |
0.77 | 0.63 | 0.65 | 0.62 | |
Depreciation/Fixed assets |
0.19 | 0.19 | 0.20 | 0.19 | |
Capex/Depreciation |
(1.29) | (1.37) | (1.45) | (1.37) | |
Revenue per Share |
1.57 | 1.55 | 1.87 | 1.88 | |
Operating CF per Share |
(0.38) | (0.32) | (0.39) | (0.42) | |
Capex per Share |
(0.10) | (0.10) | (0.13) | (0.12) | |
Capex to Sales |
0.06 | 0.06 | 0.07 | 0.06 |
Columns are period end dates